Daelemans Lab
Daelemans Lab applies CRISPR/Cas technology to virology and oncology research to develop novel therapies.
The lab combines virology and cell biology to understand virus-host cell interactions and develop antiviral therapies, expanding research into cancer and other human diseases. Part of the Molecular Genetic and Therapeutics in Virology and Oncology (MOVION) research group at the Rega Institute, KU Leuven.